Tonix Pharmaceuticals Holding Corp

NASDAQ:TNXP   3:59:57 PM EDT
1.39
-0.02 (-1.42%)
4:51:59 PM EDT: $1.37 -0.02 (-1.44%)
Products, Regulatory

Tonix Pharmaceuticals Announces Issuance Of U.S. Patent Covering Potentiated Intranasal Oxytocin (TNX-1900) For The Treatment Of Pain

Published: 08/01/2022 12:07 GMT
Tonix Pharmaceuticals Holding Corp (TNXP) - Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering Potentiated Intranasal Oxytocin (tnx-1900) for the Treatment of Pain.
Tonix Pharmaceuticals Holding Corp - New Patent Expected to Expire in 2036.
Tonix Pharmaceuticals Holding Corp - Phase 2 Study for Prevention of Migraine Headache Expected to Start Second Half 2022.